Peter J. Mazzone

18.1k total citations · 7 hit papers
155 papers, 7.7k citations indexed

About

Peter J. Mazzone is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter J. Mazzone has authored 155 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Pulmonary and Respiratory Medicine, 33 papers in Oncology and 29 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter J. Mazzone's work include Lung Cancer Diagnosis and Treatment (82 papers), Lung Cancer Treatments and Mutations (48 papers) and Radiomics and Machine Learning in Medical Imaging (19 papers). Peter J. Mazzone is often cited by papers focused on Lung Cancer Diagnosis and Treatment (82 papers), Lung Cancer Treatments and Mutations (48 papers) and Radiomics and Machine Learning in Medical Imaging (19 papers). Peter J. Mazzone collaborates with scholars based in United States, United Kingdom and Canada. Peter J. Mazzone's co-authors include David P. Naidich, Renda Soylemez Wiener, Michael K. Gould, Frank C. Detterbeck, Jessica Donington, David E. Midthun, Tarek Mekhail, William R. Lynch, Louis Lam and Gerard A. Silvestri and has published in prestigious journals such as The Lancet, JAMA and Journal of Clinical Oncology.

In The Last Decade

Peter J. Mazzone

152 papers receiving 7.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer?

2013 958 citations Michael K. Gould, Peter J. Mazzone et al. CHEST Journal profile →
Detection of Lung Cancer by Sensor Array Analyses of Exhaled Breath

2005 483 citations Roberto F. Machado, Daniel Laskowski et al. American Journal of Respiratory and Critical Care Medicine profile →
Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges

2018 357 citations Avrum Spira, Peter J. Mazzone et al. profile →
Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer

2017 349 citations Peter J. Mazzone et al. CHEST Journal profile →
Screening for Lung Cancer

2013 325 citations Frank C. Detterbeck, Peter J. Mazzone et al. CHEST Journal profile →
Evaluating the Patient With a Pulmonary Nodule

2022 230 citations Peter J. Mazzone et al. profile →
Screening for Lung Cancer

2021 127 citations Peter J. Mazzone, Gerard A. Silvestri et al. CHEST Journal profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Peter J. Mazzone	4.7k	1.6k	1.5k	1.5k	989	155	7.7k
John H. M. Austin	5.1k 1.1×	863 0.5×	728 0.5×	2.0k 1.4×	934 0.9×	133	7.8k
Lorenzo Spaggiari	6.3k 1.3×	2.9k 1.9×	554 0.4×	1.4k 0.9×	1.6k 1.6×	507	10.4k
Feng‐Ming Kong	6.0k 1.3×	2.1k 1.4×	775 0.5×	4.9k 3.2×	1.3k 1.3×	390	10.6k
Jan P. van Meerbeeck	10.6k 2.3×	5.5k 3.5×	607 0.4×	1.9k 1.2×	2.5k 2.5×	389	15.1k
Stephen Lam	7.0k 1.5×	2.5k 1.6×	2.0k 1.3×	1.7k 1.1×	4.4k 4.4×	299	14.7k
Anne‐Marie C. Dingemans	5.7k 1.2×	4.9k 3.1×	421 0.3×	1.9k 1.2×	1.8k 1.8×	368	10.2k
Bernard Lacour	2.0k 0.4×	1.4k 0.9×	633 0.4×	373 0.2×	1.4k 1.4×	309	8.8k
Anil Vachani	2.7k 0.6×	2.1k 1.3×	479 0.3×	626 0.4×	1.5k 1.5×	193	6.0k
Jan‐Willem J. Lammers	4.6k 1.0×	1.7k 1.0×	261 0.2×	1.2k 0.8×	2.7k 2.8×	184	10.7k
Kevin M. Koch	940 0.2×	2.4k 1.5×	895 0.6×	2.1k 1.4×	1.8k 1.9×	194	7.4k

Countries citing papers authored by Peter J. Mazzone

Since Specialization

Citations

This map shows the geographic impact of Peter J. Mazzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Mazzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Mazzone more than expected).

Fields of papers citing papers by Peter J. Mazzone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter J. Mazzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Mazzone. The network helps show where Peter J. Mazzone may publish in the future.

Co-authorship network of co-authors of Peter J. Mazzone

This figure shows the co-authorship network connecting the top 25 collaborators of Peter J. Mazzone. A scholar is included among the top collaborators of Peter J. Mazzone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter J. Mazzone. Peter J. Mazzone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bade, Brett C., Hiroto Hatabu, Kevin K. Brown, et al.. (2024). Interstitial Lung Abnormality. CHEST Journal. 167(3). 781–799. 2 indexed citations

Volk, Robert J., Ronald E. Myers, Douglas A. Arenberg, et al.. (2024). The American Cancer Society National Lung Cancer Roundtable strategic plan: Current challenges and future directions for shared decision making for lung cancer screening. Cancer. 130(23). 3996–4011. 3 indexed citations

Lamb, Carla, Kimberly Rieger‐Christ, Chakravarthy Reddy, et al.. (2023). A Nasal Swab Classifier to Evaluate the Probability of Lung Cancer in Patients With Pulmonary Nodules. CHEST Journal. 165(4). 1009–1019. 3 indexed citations

Barta, Julie A., et al.. (2023). Abstract CT068: CASCADE-LUNG: validation of a blood-based assay that evaluates cell-free DNA fragmentation patterns to detect lung cancer. Cancer Research. 83(8_Supplement). CT068–CT068. 1 indexed citations

Mazzone, Peter J., Kwok‐Kin Wong, Jun-Chieh J. Tsay, et al.. (2023). Abstract 5766: Prospective evaluation of cell-free DNA fragmentomes for lung cancer detection. Cancer Research. 83(7_Supplement). 5766–5766. 2 indexed citations

Silvestri, Gerard A., Lenka Goldman, Nichole T. Tanner, et al.. (2023). Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging. CHEST Journal. 164(1). 241–251. 58 indexed citations

Mazzone, Peter J., Momen M. Wahidi, Michael Bernstein, et al.. (2022). Clinical validation and utility of Percepta GSC for the evaluation of lung cancer. PLoS ONE. 17(7). e0268567–e0268567. 6 indexed citations

Choi, Humberto, Michael Ghobrial, & Peter J. Mazzone. (2018). Models to Estimate the Probability of Malignancy in Patients with Pulmonary Nodules. Annals of the American Thoracic Society. 15(10). 1117–1126. 37 indexed citations

Kathuria, Hasmeena, Frank C. Detterbeck, Joelle T. Fathi, et al.. (2017). Stakeholder Research Priorities for Smoking Cessation Interventions within Lung Cancer Screening Programs. An Official American Thoracic Society Research Statement. American Journal of Respiratory and Critical Care Medicine. 196(9). 1202–1212. 25 indexed citations

10.

Choi, Humberto, et al.. (2017). Frequency of Incidental Findings and Subsequent Evaluation in Low-Dose Computed Tomographic Scans for Lung Cancer Screening. Annals of the American Thoracic Society. 14(9). 1450–1456. 85 indexed citations

11.

Mazzone, Peter J., Xiaofeng Wang, Sung Hee Lim, et al.. (2015). Progress in the Development of Volatile Exhaled Breath Signatures of Lung Cancer. Annals of the American Thoracic Society. 12(5). 752–757. 28 indexed citations

12.

Mazzone, Peter J., et al.. (2014). The Analysis of Small Molecule Metabolite Profiles in the Blood as a Biomarker of Lung Cancer. CHEST Journal. 146(4). 587A–587A. 1 indexed citations

13.

Ha, Duc, et al.. (2014). Survival in Patients with Metachronous Second Primary Lung Cancer. Annals of the American Thoracic Society. 12(1). 79–84. 19 indexed citations

14.

Mazzone, Peter J., Xiaofeng Wang, Paul Rhodes, et al.. (2013). The Analysis of Volatile Organic Compound Profiles in the Breath as a Biomarker of Lung Cancer. CHEST Journal. 144(4). 645A–645A. 3 indexed citations

15.

Choi, Humberto, et al.. (2013). S100B as a Serum Marker for Early Detection of Brain Metastasis in Lung Cancer. CHEST Journal. 144(4). 644A–644A. 1 indexed citations

16.

Mazzone, Peter J., Nancy A. Obuchowski, Alex Z. Fu, Michael Phillips, & Moulay A. Meziane. (2013). Quality of Life and Healthcare Use in a Randomized Controlled Lung Cancer Screening Study. Annals of the American Thoracic Society. 10(4). 324–329. 20 indexed citations

17.

Mazzone, Peter J., et al.. (2010). The Effect of Metformin and Thiazolidinedione Use on Lung Cancer. CHEST Journal. 138(4). 882A–882A. 4 indexed citations

18.

Gildea, Thomas R., et al.. (2009). THE EVOLUTION OF ELECTROMAGNETIC NAVIGATION BRONCHOSCOPY. CHEST Journal. 136(4). 85S–85S. 1 indexed citations

19.

Machado, Roberto F., Daniel Laskowski, Shuo Zheng, et al.. (2005). Detection of Lung Cancer by Sensor Array Analyses of Exhaled Breath. American Journal of Respiratory and Critical Care Medicine. 171(11). 1286–1291. 483 indexed citations breakdown →

20.

Erzurum, Serpil C., Daniel Laskowski, Peter J. Mazzone, et al.. (2005). Can the Electronic Nose Really Sniff out Lung Cancer?. American Journal of Respiratory and Critical Care Medicine. 172(8). 1060–1061. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact